Matches in SemOpenAlex for { <https://semopenalex.org/work/W3128096706> ?p ?o ?g. }
- W3128096706 endingPage "1040" @default.
- W3128096706 startingPage "1040" @default.
- W3128096706 abstract ": Immune checkpoint inhibitors (ICPIs) have revolutionized the treatment paradigm of a wide range of malignancies with durable responses seen in even advanced, refractory cancers. Unfortunately, only a small proportion of patients with cancer derive meaningful benefit to ICPI therapy, and its use is also limited by significant immune and financial toxicities. Thus, there is a critical need for the development of biomarkers to reliably predict response to ICPI therapy. Only a few biomarkers are validated and approved for use with currently Food and Drug administration (FDA)-approved ICPIs. The development and broad application of biomarkers is limited by the lack of complete understanding of the complex interactions of tumor-host environment, the effect of immunotherapies on these already complex interactions, a lack of standardization and interpretation of biomarker assays across tumor types. Despite these challenges, the field of identifying predictive biomarkers is evolving at an unprecedented pace leaving the clinician responsible for identifying the patients that may derive optimal benefit from ICPIs. In this review, we provide clinicians with a current and practical update on the key, clinically relevant biomarkers of response to ICPIs. We categorize the current and emerging biomarkers of response to ICPIs in four major categories that govern anticancer response—the inflamed tumor, tumor antigens, immune suppression, and overall host environment." @default.
- W3128096706 created "2021-02-15" @default.
- W3128096706 creator A5007121755 @default.
- W3128096706 creator A5024457228 @default.
- W3128096706 creator A5037657896 @default.
- W3128096706 creator A5043773782 @default.
- W3128096706 creator A5059588535 @default.
- W3128096706 date "2021-06-01" @default.
- W3128096706 modified "2023-09-28" @default.
- W3128096706 title "Biomarkers of therapeutic response with immune checkpoint inhibitors" @default.
- W3128096706 cites W1506356232 @default.
- W3128096706 cites W1510735640 @default.
- W3128096706 cites W1516453481 @default.
- W3128096706 cites W1893792948 @default.
- W3128096706 cites W1940241680 @default.
- W3128096706 cites W1973251492 @default.
- W3128096706 cites W1974991710 @default.
- W3128096706 cites W1984642649 @default.
- W3128096706 cites W1994993231 @default.
- W3128096706 cites W2001538359 @default.
- W3128096706 cites W2004630197 @default.
- W3128096706 cites W2013090484 @default.
- W3128096706 cites W2015260577 @default.
- W3128096706 cites W2016789384 @default.
- W3128096706 cites W2034330444 @default.
- W3128096706 cites W2036464787 @default.
- W3128096706 cites W2039123767 @default.
- W3128096706 cites W2044200527 @default.
- W3128096706 cites W2046972425 @default.
- W3128096706 cites W2049553585 @default.
- W3128096706 cites W2057893793 @default.
- W3128096706 cites W2076910098 @default.
- W3128096706 cites W2087751238 @default.
- W3128096706 cites W2104885590 @default.
- W3128096706 cites W2107429737 @default.
- W3128096706 cites W2112331024 @default.
- W3128096706 cites W2119114298 @default.
- W3128096706 cites W2120338564 @default.
- W3128096706 cites W2121190621 @default.
- W3128096706 cites W2128758225 @default.
- W3128096706 cites W2131348295 @default.
- W3128096706 cites W2136807515 @default.
- W3128096706 cites W2137695731 @default.
- W3128096706 cites W2139591061 @default.
- W3128096706 cites W2142300779 @default.
- W3128096706 cites W2147598914 @default.
- W3128096706 cites W2152061559 @default.
- W3128096706 cites W2154546296 @default.
- W3128096706 cites W2158899629 @default.
- W3128096706 cites W2159999569 @default.
- W3128096706 cites W2160834915 @default.
- W3128096706 cites W2165365045 @default.
- W3128096706 cites W2168635759 @default.
- W3128096706 cites W2170137783 @default.
- W3128096706 cites W2181129638 @default.
- W3128096706 cites W2181134504 @default.
- W3128096706 cites W2210073947 @default.
- W3128096706 cites W2289712604 @default.
- W3128096706 cites W2293531514 @default.
- W3128096706 cites W2299919100 @default.
- W3128096706 cites W2318233342 @default.
- W3128096706 cites W2337659275 @default.
- W3128096706 cites W2341661619 @default.
- W3128096706 cites W2401455386 @default.
- W3128096706 cites W2433046934 @default.
- W3128096706 cites W2435243879 @default.
- W3128096706 cites W2488061344 @default.
- W3128096706 cites W2528220687 @default.
- W3128096706 cites W2529308344 @default.
- W3128096706 cites W2529484692 @default.
- W3128096706 cites W2530516001 @default.
- W3128096706 cites W2559804019 @default.
- W3128096706 cites W2560367415 @default.
- W3128096706 cites W2564105093 @default.
- W3128096706 cites W2572174216 @default.
- W3128096706 cites W2578528809 @default.
- W3128096706 cites W2622499649 @default.
- W3128096706 cites W2626312449 @default.
- W3128096706 cites W2627067328 @default.
- W3128096706 cites W2655262992 @default.
- W3128096706 cites W2725858612 @default.
- W3128096706 cites W2747272999 @default.
- W3128096706 cites W2747774814 @default.
- W3128096706 cites W2760661635 @default.
- W3128096706 cites W2760942750 @default.
- W3128096706 cites W2764165143 @default.
- W3128096706 cites W2766903152 @default.
- W3128096706 cites W2767034994 @default.
- W3128096706 cites W2769419513 @default.
- W3128096706 cites W2769855452 @default.
- W3128096706 cites W2774712455 @default.
- W3128096706 cites W2775505643 @default.
- W3128096706 cites W2779098860 @default.
- W3128096706 cites W2779221466 @default.
- W3128096706 cites W2782333299 @default.
- W3128096706 cites W2783897381 @default.
- W3128096706 cites W2784174743 @default.
- W3128096706 cites W2788797147 @default.